Viiral
Viiral is developing a nasal spray aimed at protecting against virus infections in the upper airways and maintaining a healthy nose. The product emphasizes keeping mucous membranes moist as a key measure to prevent viruses from entering through the nasal mucosa. The company is expanding its market presence with distribution partners across Europe, Asia, and the Middle East, and aims to bring its product to a global audience.
Industries
Nr. of Employees
small (1-50)
Products
Nasal spray for upper‑airway prophylaxis
A nasal spray product designed to help maintain mucous membrane moisture in the nasal cavity and to provide prophylactic protection against upper airway viral infections; subject to clinical and post‑market evaluation.
ColdZyme Mouth Spray
An oral spray evaluated for reducing the duration of upper respiratory tract infection symptoms in competitive endurance athletes under free-living conditions.
ColdZyme
A glycerol and cod trypsin-containing mouth spray that forms a protective barrier in the throat to deactivate common cold viruses.
Nasal spray for upper‑airway prophylaxis
A nasal spray product designed to help maintain mucous membrane moisture in the nasal cavity and to provide prophylactic protection against upper airway viral infections; subject to clinical and post‑market evaluation.
ColdZyme Mouth Spray
An oral spray evaluated for reducing the duration of upper respiratory tract infection symptoms in competitive endurance athletes under free-living conditions.
ColdZyme
A glycerol and cod trypsin-containing mouth spray that forms a protective barrier in the throat to deactivate common cold viruses.
Services
Coordination with regional distribution partners to supply and expand market presence across Europe, Asia and the Middle East.
Coordination with regional distribution partners to supply and expand market presence across Europe, Asia and the Middle East.
Expertise Areas
- Clinical trial management (prospective multicenter randomized controlled trials)
- Post‑market clinical follow‑up and compliance
- Antiviral product R&D using human nasal epithelial models
- Nasal spray formulation and mucosal hydration approaches
Key Technologies
- Nasal spray formulation
- Sialic acid‑based mucosal agent
- In‑vitro viral transduction assays
- Primary human nasal epithelial cell culture